Coya Therapeutics (COYA) Total Liabilities (2021 - 2026)

Coya Therapeutics has disclosed Total Liabilities across 6 years of filings, most recently posting $4.0 million for Q2 2026.

• In Q2 2026, Total Liabilities fell 21.59% year-over-year to $4.0 million; the TTM figure through Jun 2026 stood at $4.0 million (down 21.59% YoY), while the FY2025 annual figure was $6.9 million, up 45.12% from the prior year.
• Total Liabilities came in at $4.0 million for Q2 2026 at Coya Therapeutics, down from $4.3 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $16.8 million in Q4 2022 to a low of -$2.0 million in Q1 2022.
• Average Total Liabilities over 5 years is $4.4 million, with a median of $4.7 million recorded in 2024.
• Year-over-year, Total Liabilities surged 1361.98% in 2022 and slumped 66.49% in 2023.
• Over 5 years, Total Liabilities stood at $16.8 million in 2022, then slumped by 66.49% to $5.6 million in 2023, then declined by 15.23% to $4.8 million in 2024, then jumped by 45.12% to $6.9 million in 2025, then sank by 41.75% to $4.0 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $4.0 million in Q2 2026, $4.3 million in Q1 2026, and $6.9 million in Q4 2025.